0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022
Published Date: February 2019
|
Report Code: DPIR-Diag-02
Home | Market Reports | Health | Medical Facilities & Services | Medical Procedures
United States Breast Cancer Screening Market 2017 2022

United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022

Code: DPIR-Diag-02
Report
February 2019
130 Pages
DPI Research
Region: North America, South America,
Description
Table of Content
Tables & Figures

United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.

Long–term Growth Projection:

• Mammography grasp the dominant share in the United States Breast Cancer Screening Market
• Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
• Number of mammograpy screening population in United States will increase to more than 50 Million by 2022
 
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.

“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.

Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.


The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends

Key Topics Covered in the Report

• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Breast Cancer Screening (2010 – 2022)
• Market Share: United States Breast Cancer Screening (2010 – 2022)
• By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
• Key Manufacturers Analysis


Major Breast Cancer Screening Analyzed Under This Report Are:

• Mammography
• Breast Magnetic Resonance Imaging(MRI)
• Breast Ultrasound

Major Companies Covered in This Report:

• Hitachi Medical Corporation
• Siemen Healthineers
• Philips Healthcare
• Toshiba Medical Systems Corporation
• GE Healthcare
• Hologic

  1. Executive Summary

    2. Breast Cancer Facts

    3. United States Breast Cancer Cases & Population (2010 – 2022)
    3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
    3.2 Breast Cancer Occurrence (2010–2022)
    3.2.1 Total Breast Cancer Cases
    3.2.1.1 Breast Cancer Invasive Cases
    3.2.1.2 Breast Cancer In Situ Cases
    3.2.1.3 Breast Cancer Men Cases
    3.3 Breast Cancer Death (2010 – 2017)
    3.3.1 Total Breast Cancer Death
    3.3.1.1 Women Breast Cancer Death
    3.3.1.2 Men Breast Cancer Death

    4. Market Overview: United States Breast Cancer Screening (2010 – 2022)

    5. Market Share: United States Breast Cancer Screening (2010 – 2022)

    6. By Types: Market Size & Analysis (2010 – 2022)
    6.1 Mammography Screening Market
    6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
    6.3 Breast Ultrasound Screening Market

    7. Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
    7.1 Market Drivers
    7.2 Market Inhibitors

    8. Reimbursement Policies of the United States Breast Cancer Screening
    8.1 Mammography
    8.2 Breast Magnetic Resonance Imaging(MRI)
    8.3 Breast Ultrasound

    9. Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
    9.1 Year 2017
    9.2 Year 2016
    9.3 Year 2015

    10. Key Manufacturers Analysis
    10.1 Hologic
    10.1.1 Business Overview
    10.1.2 Breast Cancer Screening – Marketed Products
    10.1.2.1 Mammography
    10.1.2.2 Magnetic Resonance Imaging(MRI)
    10.1.3 Breast Cancer Screening – Latest Development & Trends
    10.2 Hitachi Medical Corporation
    10.2.1 Business Overview
    10.2.2 Breast Cancer Screening – Marketed Products
    10.2.2.1 Magnetic Resonance Imaging(MRI)
    10.2.2.2 Ultrasound
    10.2.3 Breast Cancer Screening – Latest Development & Trends
    10.3 Siemens Healthineers
    10.3.1 Business Overview
    10.3.2 Breast Cancer Screening – Marketed Products
    10.3.2.1 Mammography
    10.3.2.2 Magnetic Resonance Imaging (MRI)
    10.3.3 Breast Cancer Screening – Latest Development & Trends
    10.4 Philips Healthcare
    10.4.1 Business Overview
    10.4.2 Breast Cancer Screening – Marketed Products
    10.4.2.1 Mammography
    10.4.2.2 Magnetic Resonance Imaging (MRI)
    10.4.2.3 Ultrasound
    10.4.3 Breast Cancer Screening – Latest Development & Trends
    10.5 Toshiba Medical Systems Corporation
    10.5.1 Business Overview
    10.5.2 Breast Cancer Screening – Marketed Products
    10.5.2.1 Mammography
    10.5.2.2 Magnetic Resonance Imaging (MRI)
    10.5.2.3 Ultrasound
    10.5.3 Breast Cancer Screening – Latest Development & Trends
    10.6 GE Healthcare
    10.6.1 Business Overview
    10.6.2 Breast Cancer Screening – Marketed Products
    10.6.2.1 Mammography
    10.6.2.2 Magnetic Resonance Imaging (MRI)
    10.6.2.3 Ultrasound
    10.6.3 Breast Cancer Screening – Latest Development & Trends

                List of Tables:

Table 5–1: United States –  Breast Cancer Screening Market Share(Percent),2010 – 2016
Table 5–2: United States –  Forecast for Breast Cancer Screening Market Share(Percent),2017 – 2022

List of Figures:

Figure 3–1: United States – Breast Cancer Mammography Screening Population(Thousand),2010 – 2016
Figure 3–2: United States – Breast Cancer Mammography Screening Population(Thousand),2017 – 2022
Figure 3–3: United States – Total Breast Cancer Cases(Number),2010 – 2016
Figure 3–4: United States – Forecast for Total Breast Cancer Cases(Number),2017 – 2022
Figure 3–5: United States – Breast Cancer Invasive Cases(Number),2010 – 2016
Figure 3–6: United States – Forecast for Breast Cancer Invasive Cases(Number),2017 – 2022
Figure 3–7: United States – Breast Cancer In Situ Cases(Number),2010 – 2016
Figure 3–8: United States – Forecast for Breast Cancer In Situ Cases(Number),2017 – 2022
Figure 3–9: United States – Breast Cancer Men Cases(Number),2010 – 2016
Figure 3–10: United States – Forecast for Breast Cancer Men Cases(Number),2017 – 2022
Figure 3–11: United States – Total Breast Cancer Death(Number),2010 – 2017
Figure 3–12: United States – Women Breast Cancer Death(Number),2010 – 2017
Figure 3–13: United States – Men Breast Cancer Death(Number),2010 – 2017
Figure 4–1: United States – Breast Cancer Screening Market (Million US$),2010 – 2016
Figure 4–2: United States – Forecast for Breast Cancer Screening Market (Million US$),2017 – 2022
Figure 6–1: United States – Mammography Screening Market (Million US$),2010 – 2016
Figure 6–2: United States – Forecast for Mammography Screening Market (Million US$),2017 – 2022
Figure 6–3: United States – MRI Screening Market (Million US$),2010 – 2016
Figure 6–4: United States – Forecast for MRI Screening Market (Million US$),2017 – 2022
Figure 6–5: United States – Breast Ultrasound Screening Market (Million US$),2010 – 2016
Figure 6–6: United States – Breast Ultrasound Screening Market (Million US$),2017 – 2022

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$1100
This license allows only one user to access the PDF.

Electronic (PDF)
$1700
This license allows multiple user to access the PDF.

Electronic (PDF)
$1700
This license allows all the corporate employees to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano String

RELATED REPORTS

Global and Japan Ultrasound Ablators Market Insights Forecast to 2027
Global and Japan Ultrasound Ablators Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-4B7079
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

Global and Japan Ultrasound Machines Market Insights Forecast to 2027
Global and Japan Ultrasound Machines Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-21B6868
Mon Oct 25 00:00:00 UTC 2021

Add to Cart

China Apheresis Machines Market Report Forecast 2021 2027
China Apheresis Machines Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-6233
Sat Oct 02 00:00:00 UTC 2021

Add to Cart

China Automated Immunoassay Analyzer Market Report Forecast 2021 2027
China Automated Immunoassay Analyzer Market Report & Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-34D1632
Sat Oct 02 00:00:00 UTC 2021

Add to Cart